biologics.mckesson.comHome - Biologics by McKesson

800.850.4306 Facebook Twitter LinkedIn Facebook Twitter LinkedIn Insights News Media EventsWho We Are Biologics Leadership Careers Contact Patients Providers Risk-Based Care Financial Assistance Biopharma Oncology Rare and Orphan Care Risk-Based Care Payers How to Prescribe Select Page Who We Are Biologics by McKesson specialty pharmacy is a leader in creating truly exceptional patient experiences by simplifying connections for providers and delivering personalized care for every patient who we have the honor of serving. Video transcripts available here . We Focus on Our Patients At Biologics, we focus on why we do what we do: our patients and the partners we work with. As an independent specialty pharmacy, we specialize in cancer and rare disease areas. Our goals are to simplify access to therapies and deliver personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes. We also provide benefits investigation, assist with prior authorizations and help patients find financial aid so they can afford their treatment. Take a look at what our patients have to say about their experience with us. Setting the Standard With over 25 years’ experience caring for patients with cancer and other complex and rare diseases, Biologics has a strong foundation of clinical care with our multidisciplinary care team , and we’ve built on that approach by layering in partnerships, programs and technology that allow us to further elevate the way we care for our patients and the access we can provide them. What can we help you with today? For Patients Quick delivery, financial aid, side-effect management and adherence support. For Providers Fast time to first fill, customized solutions and exceptional patient care. For Biopharma Fast time to first fill, provider engagement and patient adherence. For Payers Cost management, industry-leading access and clinical care. Biologics by McKesson News OJEMDA (tovorafenib), FDA Approved for Pediatric Low-Grade Glioma, Available at Biologics by McKesson CARY, N.C., April 23, 2024 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited... read more FABHALTA (iptacopan), FDA Approved for the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria, Available at Biologics by McKesson CARY, N.C., Dec. 20, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Novartis as a specialty pharmacy provider... read more OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson CARY, N.C., Dec.5, 2023—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by SpringWorks Therapeutics as a limited... read more 11800 Weston Parkway Cary, NC 27513 T. 800.850.4306 Legal Privacy Notice Terms of Use Nondiscrimination Notice For Patients Privacy Practices (pdf) Patient’s Rights (pdf) Learn more about McKesson Home Patients Providers Payers Biopharma News CareersLeadership Contact Resources How to Prescribe © 2024 McKesson Corporation. All Rights...